#news #biotech Adagene plans $125M IPO to go after cancer niches targeted by BMS and Pfizer

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Adagene plans $125M IPO to go after cancer niches targeted by BMS and Pfizer .Adagene plans $125M IPO to go after cancer niches targeted by BMS and Pfizer
ntaylor
Wed, 01/20/2021 – 08:52

from FierceBiotech: Biotech https://ift.tt/2KAG9ca